approval
saveZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approval
community read0 votes
Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 4
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalFeb 20, 2026 · 273d ago
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalJan 16, 2026 · 308d ago
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalOct 12, 2022 · 1500d ago
- approvalZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalOct 12, 2022 · 1500d ago
comments(0)
5-min edit window · permanent after that